Research ArticleArticle
Open Access
Factors Associated with Rapid Progression to Endstage Kidney Disease in Lupus Nephritis
Konstantinos Tselios, Dafna D. Gladman, Cameron Taheri, Jiandong Su and Murray B. Urowitz
The Journal of Rheumatology September 2020, jrheum.200161; DOI: https://doi.org/10.3899/jrheum.200161
Konstantinos Tselios
The University of Toronto Lupus Program is funded in part by the University Health Network, Toronto General, and Toronto Western Research Foundation. K. Tselios, MD, PhD, D.D. Gladman, MD, FRCPC, C. Taheri, BHSc, J. Su, MB, MSc, M.B. Urowitz, MD, FRCPC, University of Toronto Lupus Clinic, Centre of Prognosis Studies in the Rheumatic Diseases, University Health Network, Toronto, Ontario, Canada. The authors declare no conflicts of interest. Address correspondence to Dr. M.B. Urowitz, MD, FRCPC, University of Toronto Lupus Clinic, Centre for Prognosis Studies in the Rheumatic Diseases, Toronto Western Hospital, 399 Bathurst St. 1E-410B, Toronto, ON M5T 2S8, Canada. Email: m.urowitz@utoronto.ca. Full Release Article. For details see Reprints and Permissions at jrheum.org. Accepted for publication August 14, 2020.
Dafna D. Gladman
The University of Toronto Lupus Program is funded in part by the University Health Network, Toronto General, and Toronto Western Research Foundation. K. Tselios, MD, PhD, D.D. Gladman, MD, FRCPC, C. Taheri, BHSc, J. Su, MB, MSc, M.B. Urowitz, MD, FRCPC, University of Toronto Lupus Clinic, Centre of Prognosis Studies in the Rheumatic Diseases, University Health Network, Toronto, Ontario, Canada. The authors declare no conflicts of interest. Address correspondence to Dr. M.B. Urowitz, MD, FRCPC, University of Toronto Lupus Clinic, Centre for Prognosis Studies in the Rheumatic Diseases, Toronto Western Hospital, 399 Bathurst St. 1E-410B, Toronto, ON M5T 2S8, Canada. Email: m.urowitz@utoronto.ca. Full Release Article. For details see Reprints and Permissions at jrheum.org. Accepted for publication August 14, 2020.
Cameron Taheri
The University of Toronto Lupus Program is funded in part by the University Health Network, Toronto General, and Toronto Western Research Foundation. K. Tselios, MD, PhD, D.D. Gladman, MD, FRCPC, C. Taheri, BHSc, J. Su, MB, MSc, M.B. Urowitz, MD, FRCPC, University of Toronto Lupus Clinic, Centre of Prognosis Studies in the Rheumatic Diseases, University Health Network, Toronto, Ontario, Canada. The authors declare no conflicts of interest. Address correspondence to Dr. M.B. Urowitz, MD, FRCPC, University of Toronto Lupus Clinic, Centre for Prognosis Studies in the Rheumatic Diseases, Toronto Western Hospital, 399 Bathurst St. 1E-410B, Toronto, ON M5T 2S8, Canada. Email: m.urowitz@utoronto.ca. Full Release Article. For details see Reprints and Permissions at jrheum.org. Accepted for publication August 14, 2020.
Jiandong Su
The University of Toronto Lupus Program is funded in part by the University Health Network, Toronto General, and Toronto Western Research Foundation. K. Tselios, MD, PhD, D.D. Gladman, MD, FRCPC, C. Taheri, BHSc, J. Su, MB, MSc, M.B. Urowitz, MD, FRCPC, University of Toronto Lupus Clinic, Centre of Prognosis Studies in the Rheumatic Diseases, University Health Network, Toronto, Ontario, Canada. The authors declare no conflicts of interest. Address correspondence to Dr. M.B. Urowitz, MD, FRCPC, University of Toronto Lupus Clinic, Centre for Prognosis Studies in the Rheumatic Diseases, Toronto Western Hospital, 399 Bathurst St. 1E-410B, Toronto, ON M5T 2S8, Canada. Email: m.urowitz@utoronto.ca. Full Release Article. For details see Reprints and Permissions at jrheum.org. Accepted for publication August 14, 2020.
Murray B. Urowitz
The University of Toronto Lupus Program is funded in part by the University Health Network, Toronto General, and Toronto Western Research Foundation. K. Tselios, MD, PhD, D.D. Gladman, MD, FRCPC, C. Taheri, BHSc, J. Su, MB, MSc, M.B. Urowitz, MD, FRCPC, University of Toronto Lupus Clinic, Centre of Prognosis Studies in the Rheumatic Diseases, University Health Network, Toronto, Ontario, Canada. The authors declare no conflicts of interest. Address correspondence to Dr. M.B. Urowitz, MD, FRCPC, University of Toronto Lupus Clinic, Centre for Prognosis Studies in the Rheumatic Diseases, Toronto Western Hospital, 399 Bathurst St. 1E-410B, Toronto, ON M5T 2S8, Canada. Email: m.urowitz@utoronto.ca. Full Release Article. For details see Reprints and Permissions at jrheum.org. Accepted for publication August 14, 2020.
In this issue
The Journal of Rheumatology
Vol. 51, Issue 3
1 Mar 2024
Factors Associated with Rapid Progression to Endstage Kidney Disease in Lupus Nephritis
Konstantinos Tselios, Dafna D. Gladman, Cameron Taheri, Jiandong Su, Murray B. Urowitz
The Journal of Rheumatology Sep 2020, jrheum.200161; DOI: 10.3899/jrheum.200161